AL
Last reporting period 31 Mar, 2024
Updated —
Last price
—
Market cap $B
4.457
Exchange
XNAS - Nasdaq
0.31 B
Last period Cash and equivalents ,USD
378%
Cash and equivalents has increased in 5 years
What is Cash and equivalents ?
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
See also Alpine Immune
Company Analysis
ALPN valuation, rating, competitors, insights and company profile
Eyestock Rating
ALPN financial analysis by Eyestock methodology
Valuation
ALPN valuation using historical relative method
Statements
ALPN Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ALPN dividend yield and annual dividend
Cash is the amount of free cash on the company's accounts, as well as short-term liquid investments.
Alpine Immune`s Cash and equivalents for the period ended 2024-03-31 are 0.31 B USD
